Table 3.
Odds of Naloxone Administration Before Death, New Mexico—2012.
| Variable | cOR | p-value | aORa | Confidence Limits |
|---|---|---|---|---|
| Age | ||||
| 10–29 | 5.05 | 0.17 | ||
| 30–39 | ||||
| 40–49 | ||||
| > = 50 | ||||
| Sex | ||||
| Male | 0.11 | 0.74 | ||
| Female | ||||
| Race/Ethnicity | ||||
| White, non- Hispanic | 2.21 | 0.33 | ||
| White, Hispanic | ||||
| Other | ||||
| Location of Death | ||||
| Died outside of home | 11.56 | <0.01 | 1 (ref) | |
| Died at home | 0.36 | 0.19–0.66 | ||
| Witnessed death | ||||
| No | 16.87 | <0.01 | 1 (ref) | |
| Yes | 2.24 | 1.16–4.32 | ||
| Drug paraphernalia present | ||||
| No | 1.26 | 0.26 | ||
| Yes | ||||
| Signs of injection | ||||
| No | 10.92 | <0.01 | 1 (ref) | |
| Yes | 2.29 | 1.07–4.92 | ||
| Drug type | ||||
| OPR | 8.11 | 0.02 | 1 (ref) | |
| Heroin | 1.40 | 0.62–3.17 | ||
| Mixed/Other | 0.92 | 0.44–1.93 | ||
| Substance abuse history | ||||
| No | 2.83 | 0.09 | 1 (ref) | |
| Yes | 5.07 | 0.65–39.80 | ||
| Overdose history | ||||
| No | 1.00 | 0.99 | ||
| Yes | ||||
| Chronic pain | ||||
| No | 1.61 | 0.20 | ||
| Yes | ||||
| Mental illness history | ||||
| No | 0.27 | 0.61 | ||
| Yes | ||||
| Abnormal behaviorb | ||||
| No | 0.25 | 0.88 | ||
| Yes | ||||
| Abnormal sleep signsc | ||||
| No | 8.23 | <0.01 | 1 (ref) | |
| Yes | 1.94 | 0.84–4.48 | ||
Adjusted via backwards selection from a full model for variables with cOR p < 0.1.
Abnormal behavior: drowsiness, confusion, agitation, or vomiting.
Abnormal sleep signs: snoring, choking, gurgling, other respiratory abnormalities